World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
84
Citations
36967
World Ranking
14866
National Ranking
7517

Overview

Luc G. T. Morris is affiliated with the Memorial Sloan Kettering Cancer Center in the United States. Their research focuses extensively on the field of Medicine, with a significant emphasis on Oncology, Surgery, Pulmonary and Respiratory Medicine, Cancer Research, and Otorhinolaryngology.

The main topics of study for this scientist include cancer immunotherapy and biomarkers, head and neck cancer studies, cancer genomics and diagnostics, lung cancer treatments and mutations, thyroid cancer diagnosis and treatment, salivary gland tumors diagnosis and treatment, and ferroptosis and cancer prognosis.

Luc G. T. Morris has contributed to numerous publications, with frequent appearances in several high-impact journals. The most common publication venues include:

  • Cancer
  • JAMA Otolaryngology-Head & Neck Surgery
  • Journal of Clinical Oncology
  • Cancers
  • Zenodo (CERN European Organization for Nuclear Research)

The scientist's recent papers include:

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients, 2022, Cell
  • Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic, 2020, JAMA Otolaryngology-Head & Neck Surgery
  • Pretreatment neutrophil-to-lymphocyte ratio and mutational burden as biomarkers of tumor response to immune checkpoint inhibitors, 2021, Nature Communications
  • The association between tumor mutational burden and prognosis is dependent on treatment context, 2021, Nature Genetics
  • Improved prediction of immune checkpoint blockade efficacy across multiple cancer types, 2021, Nature Biotechnology

Frequent co-authors collaborating with Luc G. T. Morris include:

  • Ian Ganly
  • Cristina Valero
  • Christopher H. Crane
  • Patrick K. Ha
  • Richard J. Wong

Best Publications

  • Comprehensive genomic characterization of head and neck squamous cell carcinomas

    Michael S. Lawrence;Carrie Sougnez;Lee Lichtenstein;Kristian Cibulskis

  • Tumor mutational load predicts survival after immunotherapy across multiple cancer types.

    Robert M Samstein;Chung-Han Lee;Chung-Han Lee;Alexander N Shoushtari;Alexander N Shoushtari;Matthew D Hellmann;Matthew D Hellmann

  • Mutational landscape of metastatic cancer revealed from prospective clinical sequencing of 10,000 patients

    Ahmet Zehir;Ryma Benayed;Ronak H Shah;Aijazuddin Syed

  • Tumor and Microenvironment Evolution during Immunotherapy with Nivolumab.

    Nadeem Riaz;Jonathan J. Havel;Vladimir Makarov;Alexis Desrichard

  • IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype

    Sevin Turcan;Daniel Rohle;Daniel Rohle;Anuj Goenka;Logan A. Walsh

  • Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy

    Diego Chowell;Luc G. T. Morris;Claud M. Grigg;Jeffrey K. Weber

  • The head and neck cancer immune landscape and its immunotherapeutic implications.

    Rajarsi Mandal;Yasin Şenbabaoğlu;Alexis Desrichard;Jonathan J. Havel

  • The increasing incidence of thyroid cancer: the influence of access to care.

    Luc G.T. Morris;Andrew G. Sikora;Tor D. Tosteson;Louise Davies;Louise Davies

  • Safety Recommendations for Evaluation and Surgery of the Head and Neck During the COVID-19 Pandemic.

    Babak Givi;Bradley A. Schiff;Steven B. Chinn;Daniel Clayburgh

  • Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response

    Rajarsi Mandal;Rajarsi Mandal;Robert M. Samstein;Ken Wing Lee;Jonathan J. Havel

  • The Mutational Landscape of Adenoid Cystic Carcinoma

    Allen S Ho;Kasthuri Kannan;David M Roy;Luc G T Morris

  • Characterization of HPV and host genome interactions in primary head and neck cancers.

    Michael Parfenov;Chandra Sekhar Pedamallu;Nils Gehlenborg;Nils Gehlenborg;Samuel S. Freeman

  • Natural History and Tumor Volume Kinetics of Papillary Thyroid Cancers During Active Surveillance

    R. Michael Tuttle;James A. Fagin;Gerald Minkowitz;Richard J. Wong

  • Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation

    Luc G T Morris;Andrew M Kaufman;Yongxing Gong;Deepa Ramaswami

  • Second Primary Cancers After an Index Head and Neck Cancer: Subsite-Specific Trends in the Era of Human Papillomavirus–Associated Oropharyngeal Cancer

    Luc G.T. Morris;Andrew G. Sikora;Snehal G. Patel;Richard B. Hayes

  • Loss of the FAT1 Tumor Suppressor Promotes Resistance to CDK4/6 Inhibitors via the Hippo Pathway

    Zhiqiang Li;Pedram Razavi;Pedram Razavi;Qing Li;Weiyi Toy

  • Malignancy rate in thyroid nodules classified as bethesda category III (AUS/FLUS)

    Allen S. Ho;Evan E. Sarti;Kunal S. Jain;Hangjun Wang

  • Rising incidence of second cancers in patients with low‐risk (T1N0) thyroid cancer who receive radioactive iodine therapy

    N. Gopalakrishna Iyer;Luc G. T. Morris;R. Michael Tuttle;Ashok R. Shaha

  • Immunogenic neoantigens derived from gene fusions stimulate T cell responses.

    Wei Yang;Ken Wing Lee;Raghvendra M. Srivastava;Fengshen Kuo

  • Genomic characterization of metastatic patterns from prospective clinical sequencing of 25,000 patients

    Bastien Nguyen;Christopher Fong;Anisha Luthra;Shaleigh A. Smith

Frequent Co-Authors

Ian Ganly
Ian Ganly Memorial Sloan Kettering Cancer Center
Timothy A. Chan
Timothy A. Chan Cleveland Clinic
Richard J. Wong
Richard J. Wong Memorial Sloan Kettering Cancer Center
Nancy Y. Lee
Nancy Y. Lee Memorial Sloan Kettering Cancer Center
Snehal G. Patel
Snehal G. Patel Memorial Sloan Kettering Cancer Center
Jatin P. Shah
Jatin P. Shah Memorial Sloan Kettering Cancer Center
Ashok R. Shaha
Ashok R. Shaha Memorial Sloan Kettering Cancer Center
Ronald Ghossein
Ronald Ghossein Memorial Sloan Kettering Cancer Center
David G. Pfister
David G. Pfister Memorial Sloan Kettering Cancer Center
Vladimir Makarov
Vladimir Makarov Memorial Sloan Kettering Cancer Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a medical career doesn't always mean enrolling in a traditional MD program. There are diverse online options in the healthcare field that lead to rewarding roles in administration, pharmacy, nursing, and health informatics. These alternative pathways can offer both flexibility and affordability.

If you’re interested in leading organizations, a masters in healthcare administration cost is often lower through online programs, making this degree more accessible. For nurses aiming for the highest clinical qualifications, the best dnp programs online provide advanced practice and leadership opportunities. Those drawn to pharmacy can benefit from pursuing an online pharmacy degree, which prepares graduates for the evolving pharmacy landscape.

Health information management is another fast-growing area, supporting patient care with technology and data. Accredited online rhit degree programs can be the stepping stone to roles in managing and securing health records.

Each of these pathways supports different interests and strengths, offering ways to make a real impact in healthcare—often with the flexibility and lower costs of online learning.

Best Scientists Citing Luc G. T. Morris

Trending Scientists